CSIMarket
 


Cyclacel Pharmaceuticals Inc   (CYCC)
Other Ticker:  
 
 

Cyclacel Pharmaceuticals Inc Asset Turnover Ratio

Quarterly Results, Trends, Rankings, Statistics

Cyclacel Pharmaceuticals Inc 's asset turnover ratio has remained unchanged compare to previous quarter at 0.02 in the third quarter (Sep 30 2023)

Within sector Cyclacel Pharmaceuticals Inc achieved the highest asset turnover ratio. While asset turnover ranking remained unchanged in the Third Quarter 2023 compared to previous quarter at no. .


What is Asset Turnover Ratio?
What is Cyclacel Pharmaceuticals Inc Market Share?


CYCC Asset Turnover Ratio (Sep 30 2023)
III. Quarter
(Jun 30 2023)
II. Quarter
(Mar 31 2023)
I. Quarter
(Dec 31 2022)
IV. Quarter
(Sep 30 2022)
III. Quarter
Y / Y Asset Change -59.87 % -53.62 % -44.66 % -34.42 % -31.34 %
Y / Y Revenue Change - - - - -
Asset Turnover Ratio (TTM) 0.02 0.02 - - -
CYCC's Total Ranking # # # # #
Seq. Asset Change -24.08 % -25.56 % -21.45 % -9.59 % -12.27 %
Seq. Revenue Change -95.71 % - - - -



Asset Turnover Ratio Company Ranking
Within: No.
Major Pharmaceutical Preparations Industry #
Healthcare Sector #
Overall Market #

Asset Turnover Ratio Statistics
High Average Low
0 0 0
 







Companies with similar Asset Turnover Ratio for the quarter ending Sep 30 2023, within Healthcare Sector Asset Turnover Ratio Revenues for 12 Months ending Sep 30 2023 Assets at quarter ending Sep 30 2023
Biocardia Inc  0.08 $ 0.570  Millions$ 6.764  Millions
Intelgenx Technologies Corp   0.08 $ 0.795  Millions$ 9.750  Millions
Predictive Oncology Inc   0.08 $ 1.809  Millions$ 22.483  Millions
Zomedica Corp   0.08 $ 22.049  Millions$ 277.260  Millions
Ikena Oncology Inc   0.08 $ 13.952  Millions$ 177.940  Millions
Igc Pharma Inc   0.08 $ 1.343  Millions$ 17.357  Millions
Lineage Cell Therapeutics Inc   0.08 $ 8.772  Millions$ 113.678  Millions
Dermtech Inc   0.08 $ 12.651  Millions$ 168.542  Millions
Delcath Systems Inc   0.07 $ 2.164  Millions$ 29.272  Millions
Perspective Therapeutics Inc   0.07 $ 7.750  Millions$ 105.212  Millions
Helius Medical Technologies inc   0.07 $ 0.927  Millions$ 12.662  Millions
Hyperfine Inc   0.07 $ 8.627  Millions$ 117.956  Millions
Avalo Therapeutics Inc   0.07 $ 2.250  Millions$ 30.777  Millions
Femasys Inc   0.07 $ 1.093  Millions$ 14.983  Millions
Recursion Pharmaceuticals Inc   0.07 $ 47.360  Millions$ 656.545  Millions
4d Molecular Therapeutics Inc   0.07 $ 21.989  Millions$ 304.996  Millions
Hcw Biologics Inc   0.07 $ 2.859  Millions$ 41.361  Millions
Tscan Therapeutics Inc   0.07 $ 16.933  Millions$ 245.243  Millions
Vbi Vaccines Inc  0.07 $ 8.122  Millions$ 118.163  Millions
Kymera Therapeutics Inc   0.07 $ 40.258  Millions$ 596.675  Millions
Oncocyte Corporation  0.07 $ 5.931  Millions$ 88.005  Millions
Northwest Biotherapeutics inc  0.07 $ 2.084  Millions$ 31.031  Millions
Abvc Biopharma Inc   0.06 $ 0.739  Millions$ 11.626  Millions
Beam Therapeutics Inc   0.06 $ 81.554  Millions$ 1,329.622  Millions
Lyell Immunopharma Inc   0.06 $ 48.503  Millions$ 862.089  Millions
Tff Pharmaceuticals Inc   0.05 $ 0.970  Millions$ 17.697  Millions
Cervomed Inc   0.05 $ 1.526  Millions$ 28.712  Millions
C4 Therapeutics Inc   0.05 $ 20.349  Millions$ 383.724  Millions
Clearside Biomedical Inc   0.05 $ 2.211  Millions$ 42.401  Millions
Ideaya Biosciences Inc   0.05 $ 23.484  Millions$ 453.304  Millions

Date modified: 2023-12-22T09:50:26+00:00



Help

About us

Advertise

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research. 
   Copyright © 2024 CSIMarket, Inc. All rights reserved. This site uses cookies to make your browsing experince better. By using this site, you agree to the Terms of Service and Privacy Policy - UPDATED (Read about our Privacy Policy)

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com